Company Explorer
Trend Explorer
Tree map
Stacked
Network
Map
Scatter
Exports In 2022, Japan exported $83.6M in Vaccines, human use, making it the 26th largest exporter of Vaccines, human use in the world. At the same year, Vaccines, human use was the 836th most exported product in Japan. The main destination of Vaccines, human use exports from Japan are: Indonesia ($14.4M), Chinese Taipei ($13.7M), United States ($11.7M), Vietnam ($8.77M), and Belgium ($6.87M).
The fastest growing export markets for Vaccines, human use of Japan between 2021 and 2022 were Belgium ($6.86M), United States ($4.86M), and Malawi ($2.43M).
Imports In 2022, Japan imported $8.82B in Vaccines, human use, becoming the 3rd largest importer of Vaccines, human use in the world. At the same year, Vaccines, human use was the 11th most imported product in Japan. Japan imports Vaccines, human use primarily from: Belgium ($5.91B), Spain ($2.7B), United States ($123M), France ($70.2M), and Germany ($9.84M).
The fastest growing import markets in Vaccines, human use for Japan between 2021 and 2022 were Spain ($2.42B), Belgium ($1.36B), and France ($1.22M).
COMPANIES In 2023, leading companies such as ROBERT BOSCH TOOL CORPORATION (49.5k), SUMITOMO RUBBER NORTH AMERICA, INC. (27.2k), and NISSAN NORTH AMERICA, INC. (23.3k) were at the forefront of shipping Vaccines, human use from Japan to the United States.
